Investor Alert: Securities Fraud Class Action Lawsuit Against PACS Group, Inc.
Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against PACS Group, Inc.
A securities fraud class action lawsuit has been filed against PACS Group, Inc. If you or someone you know purchased PACS common stock during their initial public offering in April 2024 or between April 11, 2024, and November 5, 2024, you might be affected.
The lawsuit alleges that PACS made false statements and failed to disclose important facts about their business practices. Specifically, it is claimed that PACS submitted false Medicare claims, billed for unnecessary therapies, and falsified documentation related to licensure and staffing.
If you incurred losses due to these allegations, you may be eligible to participate in the lawsuit. The lead plaintiff deadline is January 13, 2025. To learn more, you can visit the Kessler Topaz Meltzer & Check, LLP website or contact attorney Jonathan Naji, Esq. at (484) 270-1453 or info@ktmc.com.
It’s important to note that by participating as a lead plaintiff, you can represent all affected investors and have a say in the legal proceedings. You can also choose to do nothing and remain a member of the class action.
For more information about Kessler Topaz Meltzer & Check, LLP and their work in prosecuting class actions, you can visit their website. Remember, past results do not guarantee future outcomes.
If you want to read the full press release, you can visit the NewsfileCorp website.
